一部変更承認 against Huaiza K.K.
ファイザー株式会社 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareSeptember 1, 2023
Action summary
- Company
- Huaiza K.K.RomanizedOriginal: ファイザー株式会社Corporate Number: 5011001126167
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- 一部変更承認一部変更承認
- Action date
- September 1, 2023
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
A monovalent vaccine containing mRNA encoding the spike protein of the Omicron XBB.1.5 lineage was added.
Show original Japanese text
オミクロン株XBB.1.5系統のスパイクタンパク質をコードするmRNAを含む１価ワクチンが追加された。
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when Huaiza K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)Company info
- English name
- Huaiza K.K. Romanized
- Japanese name
- ファイザー株式会社
- Corporate Number
- 5011001126167
- Registered address
- 東京都渋谷区代々木３丁目２２番７号
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.